Literature DB >> 15185063

Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.

S Jähnichen1, O A Radtke, H H Pertz.   

Abstract

Using a series of triptans we characterized in vitro the 5-hydroxytryptamine (5-HT) receptor that mediates the contraction in guinea-pig iliac arteries moderately precontracted by prostaglandin F2alpha (PGF2alpha). Additionally, we investigated by reverse-transcriptase polymerase chain reaction (RT-PCR) which triptan-sensitive receptor is present in this tissue. Frovatriptan, zolmitriptan, rizatriptan, naratriptan, sumatriptan, and almotriptan contracted guinea-pig iliac arteries with pD2 values of 7.52+/-0.04, 6.72+/-0.03, 6.38+/-0.06, 6.22+/-0.05, 5.86+/-0.05 and 5.26+/-0.04 respectively. For comparison, the pD2 values for 5-HT and 5-carboxamidotryptamine (5-CT) were 7.52+/-0.02 and 7.55+/-0.03 respectively. In contrast to all other triptans tested, the concentration-response curve for eletriptan was biphasic (first phase: 0.01-3 microM, pD2 approximately 6.6; second phase: > or = 10 microM). Contractions to 5-HT, 5-CT, frovatriptan, zolmitriptan, rizatriptan, naratriptan, sumatriptan, almotriptan, and eletriptan (first phase) were antagonized by the 5-HT1B/1D receptor antagonist GR127935 (10 nM) and the 5-HT1B receptor antagonist SB216641 (10 nM). RT-PCR studies in guinea-pig iliac arteries showed a strong signal for the 5-HT1B receptor while expression of 5-HT1D and 5-HT1F receptors was not detected in any sample. The present results demonstrate that triptan-induced contraction in guinea-pig iliac arteries is mediated by the 5-HT1B receptor. The guinea-pig iliac artery may be used as a convenient in vitro model to study the (cardio)vascular side-effect potential of anti-migraine drugs of the triptan family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185063     DOI: 10.1007/s00210-004-0941-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  56 in total

1.  Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht(1F) receptor.

Authors:  Pankaj Bhalla; Hari S Sharma; Thierry Wurch; Petrus J Pauwels; Pramod R Saxena
Journal:  Eur J Pharmacol       Date:  2002-02-01       Impact factor: 4.432

2.  Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors.

Authors:  J M Zgombick; J A Bard; S A Kucharewicz; D A Urquhart; R L Weinshank; T A Branchek
Journal:  Neuropharmacology       Date:  1997 Apr-May       Impact factor: 5.250

Review 3.  GR127935: a potent and selective 5-HT1D receptor antagonist.

Authors:  M Skingle; D T Beattie; D I Scopes; S J Starkey; H E Connor; W Feniuk; M B Tyers
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

4.  Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.

Authors:  P De Vries; E W Willems; J P Heiligers; C M Villalón; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

Authors:  J Longmore; D Shaw; D Smith; R Hopkins; G McAllister; J D Pickard; D J Sirinathsinghji; A J Butler; R G Hill
Journal:  Cephalalgia       Date:  1997-12       Impact factor: 6.292

6.  Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.

Authors:  R W M van den Broek; P Bhalla; A Massen VanDenBrink; R de Vries; H S Sharma; P R Saxena
Journal:  Cephalalgia       Date:  2002-03       Impact factor: 6.292

7.  5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.

Authors:  I Morecroft; R P Heeley; H M Prentice; A Kirk; M R MacLean
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

8.  Amplification of responses to sumatriptan by various agonists in rabbit isolated iliac artery.

Authors:  O Yildiz; M Tuncer
Journal:  J Cardiovasc Pharmacol       Date:  1995-03       Impact factor: 3.105

9.  Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.

Authors:  Z Razzaque; M A Heald; J D Pickard; L Maskell; M S Beer; R G Hill; J Longmore
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

10.  5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.

Authors:  Z Razzaque; J D Pickard; Q-P Ma; D Shaw; K Morrison; T Wang; J Longmore
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

View more
  2 in total

Review 1.  Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response.

Authors:  Matilde Capi; Martina Curto; Luana Lionetto; Fernando de Andrés; Giovanna Gentile; Andrea Negro; Paolo Martelletti
Journal:  Ther Adv Neurol Disord       Date:  2016-06-03       Impact factor: 6.570

2.  Deletion of murine slc29a4 modifies vascular responses to adenosine and 5-hydroxytryptamine in a sexually dimorphic manner.

Authors:  Ran Wei; Stephen L Gust; David Tandio; Alexia Maheux; Khanh H Nguyen; Joanne Wang; Stephane Bourque; Frances Plane; James R Hammond
Journal:  Physiol Rep       Date:  2020-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.